News
Cipla Partners with Qilu to Supply Keytruda Biosimilar in US
Under the agreement, Qilu will be responsible for the development, regulatory registration and supply of the Keytruda biosimilar, while Cipla USA will oversee its commercialisation in the US.
imphoenix82
- September 5, 2026
- 0 Comments
- 82 Views
-
